2017

Skip to Main Content

Order by

T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Published in 2017 Listed under Poster, T

Hope

Abstract ID: 309

pdf Download Poster (671 KB)

T04 – Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors

Published in 2017 Listed under T

Iyer

Abstract ID: 288

T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors

Published in 2017 Listed under Poster, T

Nicolas

Abstract ID: 285

pdf Download Poster (849 KB)

T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET)

Published in 2017 Listed under Poster, T

Soulen

Abstract ID: 311

pdf Download Poster (475 KB)

T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen

Published in 2017 Listed under Poster, T

Yao

Abstract ID: 242

pdf Download Poster (848 KB)